As Pressure Around AI Returns Increases, Companies Using Should Know the Generative AI Basics

Mainstay Digital Banner Ad

In an era defined by rapid technological advancements, the surge of generative artificial intelligence (AI) and Large Language Models (LLMs) stands out as a particularly transformative development. It’s a trend that’s leading to a wealth of new AI-powered solutions for businesses to consider investing in, whether as part of their internal tech stack or as a potential sector of expansion. But with any nascent technology still proving its value in the world of day-to-day business operations,  To make a wise decision around generative AI solution investments, though, businesses need to know their generative AI basics.

As companies weigh the right way to use generative AI, the AI industry is at teetering point in its development where its having to prove itself as a viable investment and efficacious tool. Some reports tell a story of eagerness; according to PitchBook data, in 2023 alone, nearly 700 generative AI ventures received around $29.1 billion, a significant increase from previous years. Other organizations tell a story of wavering confidence; while the generative AI industry is seeing a boom in investment, the newest report out of Stanford’s Institute for Human-Centered Artificial Intelligence found that total private investment in AI fell for the second year in a row, guided by an understanding that AI is still riddled with both technical and go-to-market challenges.

If the larger AI industry is still having to prove itself to the market, then it’s still imperative for companies to know their generative AI basics before investing in any AI-specific or AI-supported solutions for their businesses. Where should businesses start in understanding the fundamentals, the core operational aspects, and most useful applications for generative AI?

Gerry Mecca, a seasoned technology leader and Principal at The EKG Group, breaks down the generative AI basics to help businesses better understand what they’re getting into, operationally and liability-wise, when they adopt generative AI solutions.

“These learnings make this technology somewhat what’s called a neural network. It is neural because it’s not just predictive information that says if this, then this. It is actually doing a bit of thinking for you based on its last response. So LLM, Large Language Model, think about it as like taking the entire library and sticking it in a computer and making it ready to be accessed easily,” Mecca said.

Article written by Daniel Litwin.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More